Home/Filings/4/0001062993-23-003840
4//SEC Filing

Mahoney Robert Patrick 4

Accession 0001062993-23-003840

CIK 0001907685other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:26 PM ET

Size

5.3 KB

Accession

0001062993-23-003840

Insider Transaction Report

Form 4
Period: 2023-02-14
Mahoney Robert Patrick
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Purchase)

    2023-02-14+25,00025,000 total
    Exercise: $1.30Exp: 2033-02-14Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the stock option vest on February 14, 2024, with the remaining shares vesting on a monthly basis on the 14th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on February 14, 2027.

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1
  • filerCIK 0001926986

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:26 PM ET
Size
5.3 KB